Association of subcutaneous and visceral adiposity with albuminuria: The framingham heart study

Obesity

Volumn 19, Issue 6, 2011, Pages 1284-1289

  Foster, Meredith C ^a,b   Hwang, Shih Jen ^a,b   Massaro, Joseph M ^c   Hoffmann, Udo ^d   Deboer, Ian H ^e   Robins, Sander J ^a,f   Vasan, Ramachandran S ^a,f   Fox, Caroline S ^a,b,g  

^a FRAMINGHAM HEART STUDY   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTIDETECTOR COMPUTED TOMOGRAPHY; OBESITY; SUBCUTANEOUS FAT; URINALYSIS; WAIST CIRCUMFERENCE;

ADIPOSITY; ADULT; AGED; ALBUMINURIA; ALGORITHMS; BODY MASS INDEX; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; SEVERITY OF ILLNESS INDEX; SEX CHARACTERISTICS; SUBCUTANEOUS FAT, ABDOMINAL; TOMOGRAPHY, X-RAY COMPUTED; WAIST CIRCUMFERENCE;

EID: 79957454691     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.308     Document Type: Article

References (40)

1. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-2047. (Pubitemid 350074801)
2. Gerstein HC, Mann JF, Yi Q et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286:421-426. (Pubitemid 32681484)
3. Romundstad S, Holmen J, Kvenild K, Hallan H, Ellekjaer H. Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trøndelag Health Study (HUNT), Norway. Am J Kidney Dis 2003;42:466-473. (Pubitemid 37048122)
4. Hillege HL, Fidler V, Diercks GF et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002;106:1777-1782.
5. Yuyun MF, Khaw KT, Luben R et al. Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. Int J Epidemiol 2004;33:189-198. (Pubitemid 38500176)
6. Liese AD, Hense HW, Döring A, Stieber J, Keil U. Microalbuminuria, central adiposity and hypertension in the non-diabetic urban population of the MONICA Augsburg survey 1994/95. J Hum Hypertens 2001;15:799-804. (Pubitemid 33054204)
7. Mulyadi L, Stevens C, Munro S, Lingard J, Bermingham M. Body fat distribution and total body fat as risk factors for microalbuminuria in the obese. Ann Nutr Metab 2001;45:67-71. (Pubitemid 32453702)
8. Pinto-Sietsma SJ, Navis G, Janssen WM et al. A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 2003;41:733-741. (Pubitemid 36401550)
9. de Boer IH, Sibley SD, Kestenbaum B et al. Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study. J Am Soc Nephrol 2007;18:235-243. (Pubitemid 46053436)
10. Chandie Shaw PK, Berger SP, Mallat M et al. Central obesity is an independent risk factor for albuminuria in nondiabetic South Asian subjects. Diabetes Care 2007;30:1840-1844. (Pubitemid 47036361)
11. Lin CC, Liu CS, Li TC et al. Microalbuminuria and the metabolic syndrome and its components in the Chinese population. Eur J Clin Invest 2007;37:783-790.
12. Kramer H, Reboussin D, Bertoni AG et al. Obesity and albuminuria among adults with type 2 diabetes: the Look AHEAD (Action for Health in Diabetes) Study. Diabetes Care 2009;32:851-853.
13. Fox CS, Massaro JM, Hoffmann U et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007;116:39-48. (Pubitemid 47016245)
14. Pascot A, Lemieux S, Lemieux I et al. Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women. Diabetes Care 1999;22:1471-1478. (Pubitemid 29418241)
15. Goodpaster BH, Krishnaswami S, Resnick H et al. Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care 2003;26: 372-379. (Pubitemid 36929058)
16. Nicklas BJ, Penninx BW, Ryan AS et al. Visceral adipose tissue cutoffs associated with metabolic risk factors for coronary heart disease in women. Diabetes Care 2003;26:1413-1420. (Pubitemid 36929172)
17. Hayashi T, Boyko EJ, Leonetti DL et al. Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans. Ann Intern Med 2004;140:992-1000.
18. Goodpaster BH, Krishnaswami S, Harris TB et al. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med 2005;165:777-783. (Pubitemid 40569431)
19. Nielsen S, Jensen MD. Relationship between urinary albumin excretion, body composition, and hyperinsulinemia in normotensive glucose-tolerant adults. Diabetes Care 1999;22:1728-1733. (Pubitemid 29458401)
20. Asakawa H, Tokunaga K, Kawakami F. Relationship of abdominal fat with metabolic disorders in diabetes mellitus patients. Diabetes Res Clin Pract 2002;55:139-149. (Pubitemid 34051311)
21. Sibley SD, de Boer IH, Steffes MW, Brunzell JD. Intra-abdominal fat and elevated urine albumin excretion in men with type 1 diabetes. Diabetes Care 2007;30:1898-1900. (Pubitemid 47036378)
22. Hanai K, Babazono T, Nyumura I et al. Involvement of visceral fat in the pathogenesis of albuminuria in patients with type 2 diabetes with early stage of nephropathy. Clin Exp Nephrol 2010;14:132-136.
23. Maurovich-Horvat P, Massaro J, Fox CS et al. Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography. Int J Obes (Lond) 2007;31:500-506.
24. Warram JH, Gearin G, Laffel L, Krolewski AS. Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol 1996;7:930-937. (Pubitemid 27465988)
25. Epstein M. Aging and the kidney. J Am Soc Nephrol 1996;7:1106-1122. (Pubitemid 27468261)
26. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 1): S1-S266.
27. Hall JE, Henegar JR, Dwyer TM et al. Is obesity a major cause of chronic kidney disease? Adv Ren Replace Ther 2004;11:41-54. (Pubitemid 38174673)
28. Pou KM, Massaro JM, Hoffmann U et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 2007;116:1234-1241. (Pubitemid 47517534)
29. Cnop M, Havel PJ, Utzschneider KM et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003;46:459-469. (Pubitemid 36577787)
30. Yatagai T, Nagasaka S, Taniguchi A et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metab Clin Exp 2003;52:1274-1278. (Pubitemid 37351094)
31. Hanley AJ, Bowden D, Wagenknecht LE et al. Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans. J Clin Endocrinol Metab 2007;92:2665-2671. (Pubitemid 47037374)
32. Tsioufis C, Dimitriadis K, Chatzis D et al. Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension. Am J Cardiol 2005;96:946-951. (Pubitemid 41362518)
33. Yano Y, Hoshide S, Ishikawa J et al. Differential impacts of adiponectin on low-grade albuminuria between obese and nonobese persons without diabetes. J Clin Hypertens (Greenwich) 2007;9:775-782.
34. Sharma K, Ramachandrarao S, Qiu G et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 2008;118: 1645-1656. (Pubitemid 351632369)
35. Yudkin JS, Eringa E, Stehouwer CD. "Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 2005;365:1817-1820. (Pubitemid 40744663)
36. Lovejoy JC, Sainsbury A. Sex differences in obesity and the regulation of energy homeostasis. Obes Rev 2009;10:154-167.
37. Sandberg K. Mechanisms underlying sex differences in progressive renal disease. Gend Med 2008;5:10-23. (Pubitemid 351506543)
38. Maric C. Sex, diabetes and the kidney. Am J Physiol Renal Physiol 2009;296:F680-F688.
39. Agarwal M, Selvan V, Freedman BI, Liu Y, Wagenknecht LE. The relationship between albuminuria and hormone therapy in postmenopausal women. Am J Kidney Dis 2005;45:1019-1025. (Pubitemid 40806514)
40. Zhang X, Jia Y, Jackson EK, Tofovic SP. 2-Methoxyestradiol and 2-ethoxyestradiol retard the progression of renal disease in aged, obese, diabetic ZSF1 rats. J Cardiovasc Pharmacol 2007;49:56-63. (Pubitemid 46184332)